Bupropion-induced inhibition of α7 nicotinic acetylcholine receptors expressed in heterologous cells and neurons from dorsal raphe nucleus and hippocampus

Elizabeth Vázquez-Gómez, Hugo R. Arias, Dominik Feuerbach, Marcela Miranda-Morales, Stefan Mihailescu, Katarzyna M. Targowska-Duda, Krzysztof Jozwiak, Jesús García-Colunga

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The pharmacological activity of bupropion was compared between α7 nicotinic acetylcholine receptors expressed in heterologous cells and hippocampal and dorsal raphe nucleus neurons. The inhibitory activity of bupropion was studied on GH3-α7 cells by Ca2+influx, as well as on neurons from the dorsal raphe nucleus and interneurons from the stratum radiatum of the hippocampal CA1 region by using a whole-cell voltage-clamp technique. In addition, the interaction of bupropion with the α7 nicotinic acetylcholine receptor was determined by [3H]imipramine competition binding assays and molecular docking. The fast component of acetylcholine- and choline-induced currents from both brain regions was inhibited by methyllycaconitine, indicating the participation of α7-containing nicotinic acetylcholine receptors. Choline-induced currents in hippocampal interneurons were partially inhibited by 10 μM bupropion, a concentration that could be reached in the brain during clinical administration. Additionally, both agonist-induced currents were reversibly inhibited by bupropion at concentrations that coincide with its inhibitory potency (IC50=54 μM) and binding affinity (Ki=63 μM) for α7 nicotinic acetylcholine receptors from heterologous cells. The [3H]imipramine competition binding and molecular docking results support a luminal location for the bupropion binding site(s). This study may help to understand the mechanisms of actions of bupropion at neuronal and molecular levels related with its therapeutic actions on depression and for smoking cessation.

Original languageEnglish
Pages (from-to)103-111
Number of pages9
JournalEuropean Journal of Pharmacology
Volume740
DOIs
StatePublished - 1 Jan 2014
Externally publishedYes

Fingerprint

Bupropion
Nicotinic Receptors
Hippocampus
Neurons
Imipramine
Interneurons
Choline
Hippocampal CA1 Region
Brain
Patch-Clamp Techniques
Smoking Cessation
Inhibition (Psychology)
Dorsal Raphe Nucleus
Inhibitory Concentration 50
Acetylcholine
Binding Sites
Pharmacology
Depression

Keywords

  • Antidepressants
  • Bupropion
  • Dorsal raphe nucleus
  • Hippocampus
  • Molecular docking
  • α7 nicotinic acetylcholine receptor

Cite this

Vázquez-Gómez, Elizabeth ; Arias, Hugo R. ; Feuerbach, Dominik ; Miranda-Morales, Marcela ; Mihailescu, Stefan ; Targowska-Duda, Katarzyna M. ; Jozwiak, Krzysztof ; García-Colunga, Jesús. / Bupropion-induced inhibition of α7 nicotinic acetylcholine receptors expressed in heterologous cells and neurons from dorsal raphe nucleus and hippocampus. In: European Journal of Pharmacology. 2014 ; Vol. 740. pp. 103-111.
@article{282d66da7d32429fa2f637f77be719ac,
title = "Bupropion-induced inhibition of α7 nicotinic acetylcholine receptors expressed in heterologous cells and neurons from dorsal raphe nucleus and hippocampus",
abstract = "The pharmacological activity of bupropion was compared between α7 nicotinic acetylcholine receptors expressed in heterologous cells and hippocampal and dorsal raphe nucleus neurons. The inhibitory activity of bupropion was studied on GH3-α7 cells by Ca2+influx, as well as on neurons from the dorsal raphe nucleus and interneurons from the stratum radiatum of the hippocampal CA1 region by using a whole-cell voltage-clamp technique. In addition, the interaction of bupropion with the α7 nicotinic acetylcholine receptor was determined by [3H]imipramine competition binding assays and molecular docking. The fast component of acetylcholine- and choline-induced currents from both brain regions was inhibited by methyllycaconitine, indicating the participation of α7-containing nicotinic acetylcholine receptors. Choline-induced currents in hippocampal interneurons were partially inhibited by 10 μM bupropion, a concentration that could be reached in the brain during clinical administration. Additionally, both agonist-induced currents were reversibly inhibited by bupropion at concentrations that coincide with its inhibitory potency (IC50=54 μM) and binding affinity (Ki=63 μM) for α7 nicotinic acetylcholine receptors from heterologous cells. The [3H]imipramine competition binding and molecular docking results support a luminal location for the bupropion binding site(s). This study may help to understand the mechanisms of actions of bupropion at neuronal and molecular levels related with its therapeutic actions on depression and for smoking cessation.",
keywords = "Antidepressants, Bupropion, Dorsal raphe nucleus, Hippocampus, Molecular docking, α7 nicotinic acetylcholine receptor",
author = "Elizabeth V{\'a}zquez-G{\'o}mez and Arias, {Hugo R.} and Dominik Feuerbach and Marcela Miranda-Morales and Stefan Mihailescu and Targowska-Duda, {Katarzyna M.} and Krzysztof Jozwiak and Jes{\'u}s Garc{\'i}a-Colunga",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.ejphar.2014.06.059",
language = "English",
volume = "740",
pages = "103--111",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",

}

Bupropion-induced inhibition of α7 nicotinic acetylcholine receptors expressed in heterologous cells and neurons from dorsal raphe nucleus and hippocampus. / Vázquez-Gómez, Elizabeth; Arias, Hugo R.; Feuerbach, Dominik; Miranda-Morales, Marcela; Mihailescu, Stefan; Targowska-Duda, Katarzyna M.; Jozwiak, Krzysztof; García-Colunga, Jesús.

In: European Journal of Pharmacology, Vol. 740, 01.01.2014, p. 103-111.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Bupropion-induced inhibition of α7 nicotinic acetylcholine receptors expressed in heterologous cells and neurons from dorsal raphe nucleus and hippocampus

AU - Vázquez-Gómez, Elizabeth

AU - Arias, Hugo R.

AU - Feuerbach, Dominik

AU - Miranda-Morales, Marcela

AU - Mihailescu, Stefan

AU - Targowska-Duda, Katarzyna M.

AU - Jozwiak, Krzysztof

AU - García-Colunga, Jesús

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The pharmacological activity of bupropion was compared between α7 nicotinic acetylcholine receptors expressed in heterologous cells and hippocampal and dorsal raphe nucleus neurons. The inhibitory activity of bupropion was studied on GH3-α7 cells by Ca2+influx, as well as on neurons from the dorsal raphe nucleus and interneurons from the stratum radiatum of the hippocampal CA1 region by using a whole-cell voltage-clamp technique. In addition, the interaction of bupropion with the α7 nicotinic acetylcholine receptor was determined by [3H]imipramine competition binding assays and molecular docking. The fast component of acetylcholine- and choline-induced currents from both brain regions was inhibited by methyllycaconitine, indicating the participation of α7-containing nicotinic acetylcholine receptors. Choline-induced currents in hippocampal interneurons were partially inhibited by 10 μM bupropion, a concentration that could be reached in the brain during clinical administration. Additionally, both agonist-induced currents were reversibly inhibited by bupropion at concentrations that coincide with its inhibitory potency (IC50=54 μM) and binding affinity (Ki=63 μM) for α7 nicotinic acetylcholine receptors from heterologous cells. The [3H]imipramine competition binding and molecular docking results support a luminal location for the bupropion binding site(s). This study may help to understand the mechanisms of actions of bupropion at neuronal and molecular levels related with its therapeutic actions on depression and for smoking cessation.

AB - The pharmacological activity of bupropion was compared between α7 nicotinic acetylcholine receptors expressed in heterologous cells and hippocampal and dorsal raphe nucleus neurons. The inhibitory activity of bupropion was studied on GH3-α7 cells by Ca2+influx, as well as on neurons from the dorsal raphe nucleus and interneurons from the stratum radiatum of the hippocampal CA1 region by using a whole-cell voltage-clamp technique. In addition, the interaction of bupropion with the α7 nicotinic acetylcholine receptor was determined by [3H]imipramine competition binding assays and molecular docking. The fast component of acetylcholine- and choline-induced currents from both brain regions was inhibited by methyllycaconitine, indicating the participation of α7-containing nicotinic acetylcholine receptors. Choline-induced currents in hippocampal interneurons were partially inhibited by 10 μM bupropion, a concentration that could be reached in the brain during clinical administration. Additionally, both agonist-induced currents were reversibly inhibited by bupropion at concentrations that coincide with its inhibitory potency (IC50=54 μM) and binding affinity (Ki=63 μM) for α7 nicotinic acetylcholine receptors from heterologous cells. The [3H]imipramine competition binding and molecular docking results support a luminal location for the bupropion binding site(s). This study may help to understand the mechanisms of actions of bupropion at neuronal and molecular levels related with its therapeutic actions on depression and for smoking cessation.

KW - Antidepressants

KW - Bupropion

KW - Dorsal raphe nucleus

KW - Hippocampus

KW - Molecular docking

KW - α7 nicotinic acetylcholine receptor

UR - http://www.scopus.com/inward/record.url?scp=84905563580&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2014.06.059

DO - 10.1016/j.ejphar.2014.06.059

M3 - Article

C2 - 25016090

AN - SCOPUS:84905563580

VL - 740

SP - 103

EP - 111

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

ER -